Born in 1974, grew up in Athens and London speaks fluent English, Spanish, French and Greek.
BSc Biology from Brighton University UK and Pharmaceutical Industry MBA at I.E. in Spain. Co-founder and President of the Greek Chapter of Family Business Network (FBN Greece). Since December 2020, he is VP of the British Hellenic Chamber of Commerce.
He is currently President and CEO of Cana Laboratories, a Greek Pharmaceutical company established in 1928. Since 1997 he has worked in the Pharmaceutical and Health related industry in a variety of roles.
Additionally to his main occupation at Cana Laboratories, Mr. Kanaroglou has an entrepreneurial mindset and is involved in several innovative projects such as the development of patented medical devices, cultivation of medicinal cannabis and R&D of single dose cannabinoid products. He firmly believes that the next major medical and therapeutic breakthroughs will arise from Cannabinoid substances and in this respect, is invested in his long-term vision of consolidating Cana Laboratories with these innovative and promising therapeutic areas.